Work

A Phase Ib Study of the combination of the Aurora Kinase Inhibitor Alisertib ( MLN 8237) and Bortezomib in Relapsed Multiple Myeloma

Year: 2015

Type: article

Abstract: The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.

Source: British Journal of Haematology

DOI: 10.1111/bjh.13765

Authors: Allison Rosenthal, Shaji Kumar, Craig Hofmeister, Jacob Laubach, Ravi Vij, Amylou Dueck, Katherine Gano, A. Keith Stewart

Institutions: Mayo Clinic in Arizona, Mayo Clinic, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Dana-Farber Cancer Institute, Washington University in St. Louis

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: National Cancer Institute

Awards: G1016754749, Cancer Center Support Grant

OpenAlex ID: W2158287952

FWCI: 2.035

Cites: 8

Cited by: 27

Related to: 10